We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

11 hedge funds and large institutions have $6.74M invested in Osiris Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less capital invested

Capital invested by funds: $27.5M → $6.74M (-$20.7M)

83% less funds holding

Funds holding: 6411 (-53)

92% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 53

99% less call options, than puts

Call options by funds: $1K | Put options by funds: $139K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
11
Holders Change
-53
Holders Change %
-82.81%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
Reduced
4
Closed
53
Calls
$1K
Puts
$139K
Net Calls
-$138K
Net Calls Change
+$688K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
-$234K -47,645 Closed
GCP
27
GSA Capital Partners
United Kingdom
-$233K -47,416 Closed
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
-$201K -40,884 Closed
AllianceBernstein
29
AllianceBernstein
Tennessee
-$200K -40,692 Closed
Fisher Asset Management
30
Fisher Asset Management
Washington
-$173K -35,270 Closed
TA
31
Teachers Advisors
New York
-$165K -33,650 Closed
CLOS
32
Compagnie Lombard Odier SCmA
Switzerland
-$128K -26,000 Closed
State Board of Administration of Florida Retirement System
33
State Board of Administration of Florida Retirement System
Florida
-$116K -23,569 Closed
Group One Trading
34
Group One Trading
Illinois
-$114K -23,189 Closed
HK
35
Horizon Kinetics
New York
-$103K -21,000 Closed
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
-$103K -20,882 Closed
Citigroup
37
Citigroup
New York
-$98K -20,007 Closed
PP
38
PDT Partners
New York
-$96K -19,638 Closed
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
-$93K -18,900 Closed
VKH
40
Virtu KCG Holdings
New York
-$91K -18,455 Closed
Bank of America
41
Bank of America
North Carolina
-$83K -16,874 Closed
Wells Fargo
42
Wells Fargo
California
-$78K -16,024 Closed
Citadel Advisors
43
Citadel Advisors
Florida
-$75K -15,242 Closed
PP
44
Paloma Partners
Connecticut
-$66K -13,438 Closed
CG
45
Cutler Group
California
-$64K -13,186 Closed
AIM
46
Acrospire Investment Management
Illinois
-$62K -12,610 Closed
NFA
47
Nationwide Fund Advisors
Ohio
-$61K -12,331 Closed
CS
48
Credit Suisse
Switzerland
-$60K -12,200 Closed
AIG
49
American International Group
New York
-$62K -11,421 -100%
Barclays
50
Barclays
United Kingdom
-$45K -9,377 Closed

OSIR Hedge Fund Activity: Q1 2017 in Review

11 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q1 2017, worth a combined $6.74M — down 75% from $27.5M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of OSIR and 4 opened new positions — a net loss of 49 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was HealthInvest Partners, opening a new position worth an estimated $6.19M. The largest seller was Vanguard Group, exiting entirely with an estimated $3.54M sold.

  • 11 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q1 2017, down from 64 in Q4 2016.
  • Funds reported $6.74M of Osiris Therapeutics, Inc. Common Stock stock for Q1 2017, down 75% quarter-over-quarter.
  • 4 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q1 2017 and 53 closed out, a net change of -49 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q1 2017 was HealthInvest Partners, an estimated $6.19M added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q1 2017 was Vanguard Group, an estimated $3.54M sold.

Based on aggregated 13F filings for Q1 2017.